MicroStrategy
MSTR
Coinbase
COIN
MARA Holdings
MARA
Meta Platforms
META
NVIDIA
NVDA
US Stock MarketDetailed Quotes
HIMS Hims & Hers Health
- 26.900
- +0.270+1.01%
Close Jan 6 16:00 ET
- 26.940
- +0.040+0.15%
Post 20:01 ET
5.88BMarket Cap61.14P/E (TTM)
28.200High26.360Low9.05MVolume27.350Open26.630Pre Close246.26MTurnover4.83%Turnover RatioLossP/E (Static)218.48MShares35.02052wk High13.36P/B5.04BFloat Cap8.14052wk Low--Dividend TTM187.48MShs Float35.020Historical High--Div YieldTTM6.91%Amplitude2.720Historical Low27.216Avg Price1Lot Size
Hims & Hers Health News
Piper Sandler Maintains Neutral on Hims & Hers Health, Raises Price Target to $24
Needham Maintains Hims & Hers Health(HIMS.US) With Buy Rating, Raises Target Price to $31
Hims & Hers Health Is Maintained at Buy by Needham
Hims & Hers Health Analyst Ratings
Morgan Stanley Maintains Hims & Hers Health(HIMS.US) With Buy Rating, Maintains Target Price $42
BofA Securities Maintains Hims & Hers Health(HIMS.US) With Sell Rating, Maintains Target Price $18
Truist Financial Maintains Hims & Hers Health(HIMS.US) With Hold Rating
Truist Financial Issues a Hold Rating on Hims & Hers Health (HIMS)
Hims & Hers Health: Sell Rating Due to Compounding Exemption Risks and Uncertain GLP-1 Contributions
Hims & Hers Health Initiated at Overweight by Morgan Stanley
Hims & Hers Health Analyst Ratings
Morgan Stanley Initiates Hims & Hers Health(HIMS.US) With Buy Rating, Announces Target Price $42
Analysts' Opinions Are Mixed on These Healthcare Stocks: Hims & Hers Health (HIMS), Zymeworks (ZYME) and Axsome Therapeutics (AXSM)
Truist Financial Maintains Hims & Hers Health(HIMS.US) With Hold Rating
Truist Financial Gives a Hold Rating to Hims & Hers Health (HIMS)
BofA Securities Maintains Hims & Hers Health(HIMS.US) With Sell Rating, Maintains Target Price $18
CCORF Maintains Hims & Hers Health(HIMS.US) With Buy Rating, Maintains Target Price $38
CCORF Maintains Hims & Hers Health(HIMS.US) With Buy Rating, Raises Target Price to $38
Hims & Hers Health Analyst Ratings
Canaccord Genuity Maintains Buy on Hims & Hers Health, Raises Price Target to $38
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.